Cargando…

Updates of Pathogenesis, Diagnostic and Therapeutic Perspectives for Ovarian Clear Cell Carcinoma

Ovarian clear cell carcinoma (OCCC) is a special pathological type of epithelial ovarian carcinoma (EOC) and has a high prevalence in Asia without specific molecular subtype classification. Endometriosis is a recognized precancerous lesion that carries 3-fold increased risk of OCCC. Ovarian endometr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Chenchen, Xu, Zhihao, Zhang, Tianjiao, Qian, Lili, Xiao, Weihua, Wei, Haiming, Jin, Tengchuan, Zhou, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7974897/ https://www.ncbi.nlm.nih.gov/pubmed/33758607 http://dx.doi.org/10.7150/jca.53395

Ejemplares similares

Clinical characteristics and prognosis of ovarian clear cell carcinoma: a 10-year retrospective study
por: Zhu, Chenchen, et al.
Publicado: (2021)

Potential targets for ovarian clear cell carcinoma: a review of updates and future perspectives
por: Matsuzaki, Shinya, et al.
Publicado: (2015)

Antioxidants and Therapeutic Targets in Ovarian Clear Cell Carcinoma
por: Amano, Tsukuru, et al.
Publicado: (2021)

Endometriosis-associated ovarian carcinomas: insights into pathogenesis, diagnostics, and therapeutic targets—a narrative review
por: Samartzis, Eleftherios P., et al.
Publicado: (2020)

New perspectives on molecular targeted therapy in ovarian clear cell carcinoma
por: Tan, D S P, et al.
Publicado: (2013)

Clear cell odontogenic carcinoma: a diagnostic and therapeutic dilemma
por: Avninder, Singh, et al.
Publicado: (2006)

The target therapy of ovarian clear cell carcinoma
por: Jin, Ying, et al.
Publicado: (2014)

Pathogenesis and Causes of Premature Ovarian Failure: An Update
por: Ebrahimi, Mahbod, et al.
Publicado: (2011)

Review the progression of ovarian clear cell carcinoma from the perspective of genomics and epigenomics
por: Tong, An, et al.
Publicado: (2023)

c-MET as a Potential Therapeutic Target in Ovarian Clear Cell Carcinoma
por: Kim, Ha-Jeong, et al.
Publicado: (2016)

Therapeutic significance of full lymphadenectomy in early-stage ovarian clear cell carcinoma
por: Yamazaki, Hiroyuki, et al.
Publicado: (2018)

Novel Therapeutic Strategies for Refractory Ovarian Cancers: Clear Cell and Mucinous Carcinomas
por: Shoji, Tadahiro, et al.
Publicado: (2021)

Therapeutic Strategies Focused on Cancer-Associated Hypercoagulation for Ovarian Clear Cell Carcinoma
por: Tamura, Ryo, et al.
Publicado: (2022)

Clear cell carcinoma of the ovary: molecular insights and future therapeutic perspectives
por: Mabuchi, Seiji, et al.
Publicado: (2016)

Updates on ankylosing spondylitis: pathogenesis and therapeutic agents
por: Kim, Se Hee, et al.
Publicado: (2023)

Current Position of the Molecular Therapeutic Targets for Ovarian Clear Cell Carcinoma: A Literature Review
por: Amano, Tsukuru, et al.
Publicado: (2019)

Update on the treatment of metastatic clear cell and non-clear cell renal cell carcinoma
por: Xu, Kevin Y, et al.
Publicado: (2015)

Pathogenesis and New Therapeutic Targets of Ovarian Cancer
por: Shih, Ie-Ming, et al.
Publicado: (2012)

lncRNA PART1 and MIR17HG as ΔNp63α direct targets regulate tumor progression of cervical squamous cell carcinoma
por: Liu, Hanyuan, et al.
Publicado: (2020)

Neurological involvement, immune response, and biomarkers in Kawasaki disease along with its pathogenesis, therapeutic and diagnostic updates
por: Amir, Omniat, et al.
Publicado: (2023)

Alzheimer’s disease: pathogenesis, diagnostics, and therapeutics
por: Tiwari, Sneham, et al.
Publicado: (2019)

Genomic characterization of Chinese ovarian clear cell carcinoma identifies driver genes by whole exome sequencing
por: Yang, Qin, et al.
Publicado: (2020)

The Potential Role of an Aberrant Mucosal Immune Response to SARS-CoV-2 in the Pathogenesis of IgA Nephropathy
por: Zhang, Zhao, et al.
Publicado: (2021)

Inhibition of autophagy protein LC3A as a therapeutic target in ovarian clear cell carcinomas
por: Miyamoto, Morikazu, et al.
Publicado: (2017)

Clear Cell Renal Cell Carcinoma, Diagnostic and Therapeutic Difficulties, Case Report and Literature Review
por: Stolpa, Weronika, et al.
Publicado: (2022)

Hepatocellular Carcinoma: Updates in Pathogenesis, Detection and Treatment
por: Martínez-Chantar, Maria L., et al.
Publicado: (2020)

Updates on Immunotherapy and Immune Landscape in Renal Clear Cell Carcinoma
por: Kim, Myung-Chul, et al.
Publicado: (2021)

Fully-sialylated alpha-chain of complement 4-binding protein: Diagnostic utility for ovarian clear cell carcinoma
por: Mikami, Mikio, et al.
Publicado: (2015)

Epidermolysis Bullosa-Associated Squamous Cell Carcinoma: From Pathogenesis to Therapeutic Perspectives
por: Condorelli, Angelo Giuseppe, et al.
Publicado: (2019)

Recent perspectives of epithelial ovarian carcinoma
por: Zhang, Xiao-Ying, et al.
Publicado: (2016)

Recent perspectives of epithelial ovarian carcinoma
por: Zhang, Xiao-Ying, et al.
Publicado: (2020)

Identification of Novel Therapeutic Targets in Microdissected Clear Cell Ovarian Cancers
por: Stany, Michael P., et al.
Publicado: (2011)

Distinct gene expression profiles associated with clinical outcomes in patients with ovarian clear cell carcinoma and high-grade serous ovarian carcinoma
por: Zhou, Huimei, et al.
Publicado: (2020)

CCNE1 Is a Putative Therapeutic Target for ARID1A-Mutated Ovarian Clear Cell Carcinoma
por: Kawahara, Naoki, et al.
Publicado: (2021)

Magnetic Resonance Imaging Characteristics of Ovarian Clear Cell Carcinoma
por: Wang, Wei, et al.
Publicado: (2015)

Napsin A as a marker of clear cell ovarian carcinoma
por: Skirnisdottir, Ingiridur, et al.
Publicado: (2013)

Unilateral ovarian metastasis from renal clear cell carcinoma
por: Younes, Bencherifi, et al.
Publicado: (2023)

Transcriptomic analyses of ovarian clear-cell carcinoma with concurrent endometriosis
por: Collins, Kaitlyn E., et al.
Publicado: (2023)

Differential molecular pathway expression according to chemotherapeutic response in ovarian clear cell carcinoma
por: Yin, Min, et al.
Publicado: (2023)

Insights Into the Role of Mesothelin as a Diagnostic and Therapeutic Target in Ovarian Carcinoma
por: Shen, Jiayu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qjpu4ecgla1mimdjk7cr3ruqtn